10 Must-Read Posts in Immuno-Oncology This Week
@viveksubbiah.bsky.social @jiajennyliu.bsky.social @gerryhanna.bsky.social @drjnaidoo.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmuneOncology
#MAITcells #Tcells #CARTcells #liverimmunology #MR1 #cancer #immunometabolism #Tcellengineering #immunotherapy #immuneoncology
Phase I/II of Nivo vs Ipi+Nivo in advanced Merkel Cell Carcinoma
Similar efficacy in both groups, ORR 60 vs 58%. ++toxicity with Ipi
No benefit to adding Ipi in this study, but important to ask the question in a rare cancer
#Oncsky #MedSky #Immuneoncology #RareCancers
doi.org/10.1200/JCO-...
Safety of anti-PDL1/PD1 in a solid organ transplant recipient?
Some retrospective case series out there. Recent report hints PDL1 may be less accociated with rejection than other classes
Does anyone have experience or insights?
#oncsky #LCSM #Melanoma #IO #ImmuneOncology
